Back to Annual Meeting Page
133rd Annual Meeting & Exposition
December 10-14, 2005
Philadelphia, PA
|
Back to Annual Meeting Page
|
133rd Annual Meeting & Exposition December 10-14, 2005 Philadelphia, PA |
|
|
4289.0: Tuesday, December 13, 2005: 4:30 PM-6:00 PM | |||
Oral | |||
| |||
| Learning Objectives: See individual abstracts | |||
| Richard S. Garfein, PhD, MPH | |||
| Richard S. Garfein, PhD, MPH | |||
| *SESSION ABSTRACT* HIV and HCV prevention for young adult IDUs: Findings from the CIDUS III/Drug Users Intervention Trial (DUIT) Richard S. Garfein, PhD, MPH | |||
| CIDUS-III/DUIT: Results of a peer-education-focused behavioral intervention to prevent HIV and hepatitis C virus (HCV) infection among young injection drug users (IDUs) Richard S. Garfein, PhD, MPH, Mary Latka, PhD, Holly Hagan, PhD, Lawrence Ouellet, PhD, Sharon M. Hudson, PhD, Steffanie A. Strathdee, PhD, Hanne Thiede, DVM, MPH, Elizabeth T. Golub, PhD, MPH, Susan L. Bailey, PhD, Peter Kerndt, MD, MPH, Farzana Kapadia, MPH, Debra Hanson, David Purcell | |||
| CIDUS III/DUIT: The potential role of empowerment as a mediator of intervention effect in a peer-education intervention for young adult injection drug users Sharon M. Hudson, PhD, Peter R. Kerndt, MD, MPH, Mary Latka, PhD, Holly Hagan, PhD, Elizabeth T. Golub, PhD, MPH, Susan L. Bailey, PhD | |||
CIDUS-III/DUIT: Who reduces their risk in response to a sex and drug behavioral intervention among young injection drug users (IDUs)? ![[ Recorded presentation ]](/static/img/filetypes/16x16/wrf.gif){kind=small} Mary Latka, PhD, Sharon Hudson, PhD, Elizabeth T. Golub, PhD, MPH, Hanne Thiede, DVM, MPH, Susan L. Bailey, PhD, Farzana Kapadia, MPH, Richard S. Garfein, PhD, MPH | |||
| CIDUS-III/DUIT: Opportunities for reducing sexual HIV risk among young injection drug (IDUs) through substance abuse treatment Micaela H. Coady, MS, Mary Latka, PhD, Sharon M. Hudson, PhD, Jennifer Vernon Campbell, MSPH, Susan L. Bailey, PhD, Steffanie A. Strathdee, PhD, Evie Andreopoulos, Richard S. Garfein, PhD, MPH | |||
| Hepatitis A and B virus (HAV and HBV) seroprevalence and structural factors associated with vaccine uptake among younger injection drug users (IDUs) in 5 U.S. cities Jennifer Vernon Campbell, MSPH, Richard S. Garfein, PhD, MPH, Elizabeth T. Golub, PhD, MPH, Lawrence Ouellet, PhD, Sharon Hudson, PhD, Danielle C. Ompad, PhD, Cindy Weinbaum, MD, MPH | |||
| See individual abstracts for presenting author's disclosure statement and author's information. | |||
| Organized by: | Alcohol, Tobacco, and Other Drugs | ||
| Endorsed by: | Community Health Planning and Policy Development; Public Health Education and Health Promotion; Public Health Nursing | ||
| CE Credits: | CME, Health Education (CHES), Nursing | ||
The 133rd Annual Meeting & Exposition (December 10-14, 2005) of APHA